Unknown

Dataset Information

0

Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment.


ABSTRACT: Accumulating evidence indicates that inflammation plays a critical role in cancer development; however, mechanisms of immunosuppression hinder productive anti-tumor immunity to limit immunopathology. Tumor-specific cytotoxic T lymphocyte (CTL) dysfunction or exhaustion by upregulating inhibitory receptors such as programmed cell death 1 (PD-1) in tumor-bearing hosts is one such mechanism. Identification and blockade of the pathways that induce CTL dysfunction has been shown to partially restore CTL function in tumor-bearing hosts. Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme for prostanoid biosynthesis, including prostaglandin E2 (PGE2), and plays a key role in both inflammation and cancer. The disruption of COX2/PGE2 signaling using COX2 inhibitors or PGE2 receptors EP2 and EP4 antagonists, combined with anti-PD-1 blockade was therapeutic in terms of improving eradication of tumors and augmenting the numbers of functional tumor-specific CTLs. Thus, COX2/PGE2 axis inhibition is a promising adjunct therapy to PD-1 blockade for immune-based therapies in cancer.

SUBMITTER: Miao J 

PROVIDER: S-EPMC5685710 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prostaglandin E<sub>2</sub> and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment.

Miao Jie J   Lu Xu X   Hu Yuefeng Y   Piao Chunmei C   Wu Xuan X   Liu Xuesong X   Huang Caiting C   Wang Yue Y   Li Dan D   Liu Jingwei J  

Oncotarget 20170922 52


Accumulating evidence indicates that inflammation plays a critical role in cancer development; however, mechanisms of immunosuppression hinder productive anti-tumor immunity to limit immunopathology. Tumor-specific cytotoxic T lymphocyte (CTL) dysfunction or exhaustion by upregulating inhibitory receptors such as programmed cell death 1 (PD-1) in tumor-bearing hosts is one such mechanism. Identification and blockade of the pathways that induce CTL dysfunction has been shown to partially restore  ...[more]

Similar Datasets

| S-EPMC6940958 | biostudies-literature
| S-EPMC4573903 | biostudies-literature
| S-EPMC5148837 | biostudies-literature
| S-EPMC7078948 | biostudies-literature
| S-EPMC7243284 | biostudies-literature
| S-EPMC3274627 | biostudies-literature
| S-EPMC4390444 | biostudies-literature
| S-EPMC4505619 | biostudies-literature
| S-EPMC4979008 | biostudies-literature
| S-EPMC7760298 | biostudies-literature